The use of first-generation long-acting injectable antipsychotics in children and adolescents-A retrospective audit from India.
Sign Up to like & getrecommendations! Published in 2021 at "Asian journal of psychiatry"
DOI: 10.1016/j.ajp.2021.102663
Abstract: OBJECTIVES There is a dearth of knowledge regarding the usage of first-generation long-acting injectable (LAI) antipsychotics in children and adolescents, despite their off-label use, in low and middle-income countries (LAMIC). METHODS Case records of subjects… read more here.
Keywords: first generation; lai antipsychotics; antipsychotics children; generation ... See more keywords
Comparison of clinical outcomes associated with long-acting injectable antipsychotics in people with psychotic disorders: an electronic case register study
Sign Up to like & getrecommendations! Published in 2017 at "The Lancet"
DOI: 10.1016/s0140-6736(17)30473-7
Abstract: Abstract Background Long-acting injectable (LAI) antipsychotics have been shown to reduce risk of relapse in people with psychosis. Second generation LAI antipsychotics such as paliperidone palmitate can have fewer side-effects and be better tolerated than… read more here.
Keywords: case register; lai; lai antipsychotics; paliperidone palmitate ... See more keywords
Long-acting injectable antipsychotics update: lengthening the dosing interval and expanding the diagnostic indications
Sign Up to like & getrecommendations! Published in 2017 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2017.1371014
Abstract: ABSTRACT Introduction: Long-acting injectable (LAI) antipsychotics are a useful but underutilized option in the management of schizophrenia. Areas covered: This is a narrative review of newer LAI antipsychotics approved by the US Food and Drug… read more here.
Keywords: injectable antipsychotics; lai antipsychotics; long acting; antipsychotics update ... See more keywords
Clinical and economic impact of long-acting injectable antipsychotics in patients previously treated with short-acting oral antipsychotics.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2022.28.10.1130
Abstract: BACKGROUND: Available literature supports the use of long-acting injectable (LAI) antipsychotics over short-acting oral (SAO) formulations. The majority of evidence is centered on patients with schizophrenia insured under the Medicaid benefit. OBJECTIVE: To assess real-world… read more here.
Keywords: long acting; lai antipsychotics; antipsychotics patients; spending ... See more keywords